Pharma Stocks

Truist Raises PT on Amneal Pharmaceuticals (AMRX) to $15 From $14

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is one of the best performing pharma stocks in 2025. On January 7, Truist raised the…

Read More »

Is This ‘Boring’ Pharma Stock a Secret Power Play?

Everyone’s chasing hype stocks, but Sanofi S.A. is quietly moving the health game. Is this a sneaky must-cop or a…

Read More »

Is This Pharma Giant a Silent Market Cheat Code?

Takeda looks boring on the surface, but the stock, the pipeline, and the US moves might be the sleeper play…

Read More »

Takeda Pharmaceutical (TSE:4502) Valuation Check As Shares Show Strength Over Recent Periods

Takeda Pharmaceutical (TSE:4502) has drawn investor attention after recent share price moves, with the stock showing different return profiles over…

Read More »

What’s Going On With ARS Pharmaceuticals Stock Friday? – ARS Pharmaceuticals (NASDAQ:SPRY)

ARS Pharmaceuticals Inc. (NASDAQ:SPRY) stock rose Friday in reaction to a negative update for its rival Aquestive Therapeutics Inc. (NASDAQ:AQST).…

Read More »

Quiet chart, loud pipeline as Wall Street leans bullish

Vertex Pharmaceuticals has spent the past few sessions trading in a tight range, but behind the calm tape sits a…

Read More »

Will Royalty Pharma’s (RPRX) Raised Guidance After a Revenue Miss Reframe Its Resilience Narrative?

In its latest quarterly update, Royalty Pharma reported year-on-year revenue growth of 7.9% that came in 2.6% below analyst expectations…

Read More »

Assessing Crinetics Pharmaceuticals (CRNX) Valuation After Recent Strong Share Price Momentum

What Crinetics Pharmaceuticals Stock’s Recent Move Might Mean for Investors Crinetics Pharmaceuticals (CRNX) has drawn attention after recent share price…

Read More »

Assessing Organon (OGN) Valuation After New Nilemdo Cholesterol Therapy Agreement

Why the new Nilemdo agreement matters for Organon shareholders Organon (OGN) has agreed with Daiichi Sankyo Europe to commercialize Nilemdo,…

Read More »

Evoke Pharma Achieves 304.41% Return, Leading Micro-Cap Stock Performance

In the past six months, micro-cap stocks have shown varied performance, with Evoke Pharma, Inc. leading the way in the…

Read More »